JOT Automation and Tensor ID Work on Syringe Inspection Platform - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

JOT Automation and Tensor ID Work on Syringe Inspection Platform



JOT Automation, a supplier of test and production solutions, and Tensor ID, specialists in machine vision solutions, will highlight the benefits of the companies' combined service and technology offering at ATX West as the companies exhibit together for the first time. The companies have started to codevelop a fully automated solution for the quality assurance of auto-injector syringes.

"Together we are pre-promoting an auto injection syringe inspection platform. The vision-based platform enables inspection of silicone coating inside glass syringes,” said Jorma Venäläinen, business line director of Life Sciences at JOT Automation, in the press release.

“The quality of silicone oil and its distribution on the inner syringe surface are two important factors that affect the injection performance of auto-injector devices. To better identify and screen out syringes with insufficient or non-uniform silicone oil distribution, our new technology visualizes, quantifies, and analyzes silicone oil distribution.”

"The market for auto-injectors is set to rise to 1.07 billion dollars by 2015," said Stacey Swall from Tensor ID in the press release. "In addition we see possibilities to exploit this technology for quality inspection of pipettes, vials and tubes.”

Source: JOT Automation

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Sandoz Wins Biosimilar Filing Race

Click here